| HOME >> BIOLOGY >> TECHNOLOGY |
Two Minnesota bio-science companies, The Integra Group of Brooklyn Park and Nanocopoeia of St. Paul, team in a global effort to speed the path to
market for advances in cardiovascular medicine
BROOKLYN PARK, Minn. and SAN DIEGO, June 17 /PRNewswire/ -- Coinciding with the BIO International Convention held in San Diego CA, NanoInterventions introduces the "Mouse Stent Model" for rapid screening of new coronary stent therapeutics. The model, complete with a mini-stent of spectacularly small size and its ability to replicate the human diseased vessel, represents a new starting point in the development of next-generation drug-eluting coronary stents. The company, NanoInterventions, emerged from the strategic global partnership of Minnesota-based The Integra Group of Brooklyn Park and Nanocopoeia of St. Paul, along with Stentome, with operations in Palo Alto CA, Galway, Ireland and Oxford, UK, and the University of Western Ontario, in London ON.
The Twin Cities is already home to two of the three largest stent
manufacturers and one of the largest clusters of medical device companies
in the world. With its local headquarters and base of operations, combined
with its global network of partners, NanoInterventions is ideally
positioned to speed the development of these life saving devices. The new
starting point for testing new stent-delivered therapies brings the
customer many novel benefits, including: establishing efficacy much earlier
in the process, speeding development-the experimental model requires 28 day
cycle versus a 180 day average cycle-and exploring molecular mechanisms of
action in the setting of a stented, diseased vessel. NanoInterventions'
managing partner, Robert A. Hoerr, MD, PhD, who is Nanocopoeia's CEO,
stated, "Our position within the heart of Minnesota's world-class medical
device community enabled us to build strategic relationships with the
talent and technology needed to launch this new development pathway for
'/>"/>
| SOURCE NanoInterventions Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. Novozymes Launches Enzyme to Reduce Acrylamide in Food
3. Enova Medical Launches Exos Corporation
4. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
5. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
6. ThirdBiotech Networking Group Launches
7. BioReliance Launches Next-Generation Genotoxicity Screening Service
8. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
9. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
10. Kingfisher Healthcare Launches Breakthrough Product in Europe
11. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |